A novel, de novo intronic variant in POGZ causes White-Sutton syndrome.


Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
07 2022
Historique:
revised: 25 02 2022
received: 10 01 2022
accepted: 11 03 2022
pubmed: 10 4 2022
medline: 15 6 2022
entrez: 9 4 2022
Statut: ppublish

Résumé

White-Sutton syndrome (WHSUS), which is caused by heterozygous pathogenic variants in POGZ, is characterized by a spectrum of intellectual disabilities and global developmental delay with or without features of autism spectrum disorder. Additional features may include hypotonia, behavioral abnormalities, ophthalmic abnormalities, hearing loss, sleep apnea, microcephaly, dysmorphic facial features, and rarely, congenital diaphragmatic hernia (CDH). We present a 6-year-old female with features of WHSUS, including CDH, but with nondiagnostic clinical trio exome sequencing. Exome sequencing reanalysis revealed a heterozygous, de novo, intronic variant in POGZ (NM_015100.3:c.2546-20T>A). RNA sequencing revealed that this intronic variant leads to skipping of exon 18. This exon skipping event results in a frameshift with a predicted premature stop codon in the last exon and escape from nonsense-mediated mRNA decay (NMD). To our knowledge, this case is the first case of WHSUS caused by a de novo, intronic variant that is not near a canonical splice site within POGZ. These findings emphasize the limitations of standard clinical exome filtering algorithms and the importance of research reanalysis of exome data together with RNA sequencing to confirm a suspected diagnosis of WHSUS. As the sixth reported case of CDH with heterozygous pathogenic variants in POGZ and features consistent with WHSUS, this report supports the conclusion that WHSUS should be considered in the differential diagnosis for patients with syndromic CDH.

Identifiants

pubmed: 35396900
doi: 10.1002/ajmg.a.62747
pmc: PMC9197987
mid: NIHMS1792708
doi:

Substances chimiques

POGZ protein, human 0
Transposases EC 2.7.7.-

Types de publication

Case Reports Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2198-2203

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD098458
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007526
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG007709
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG007530
Pays : United States
Organisme : NICHD NIH HHS
ID : P50 HD103555
Pays : United States

Informations de copyright

© 2022 Wiley Periodicals LLC.

Références

Am J Med Genet A. 2019 Aug;179(8):1631-1636
pubmed: 31136090
Nat Cell Biol. 2010 Jul;12(7):719-27
pubmed: 20562864
Clin Genet. 2021 Mar;99(3):407-417
pubmed: 33277917
BMC Pediatr. 2013 Apr 20;13:59
pubmed: 23601190
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
JAMA. 2014 Nov 12;312(18):1870-9
pubmed: 25326635
Am J Hum Genet. 2019 May 2;104(5):1007
pubmed: 31051109
Am J Med Genet A. 2020 Jan;182(1):38-52
pubmed: 31782611
Sci Transl Med. 2017 Apr 19;9(386):
pubmed: 28424332
Cold Spring Harb Mol Case Stud. 2015 Oct;1(1):a000455
pubmed: 27148570
Nat Commun. 2020 Feb 26;11(1):859
pubmed: 32103003
J Clin Invest. 2021 Jan 4;131(1):
pubmed: 33001864
Genome Biol. 2020 Jun 17;21(1):145
pubmed: 32552793
Nat Commun. 2017 Jun 12;8:15824
pubmed: 28604674
Dev Neurosci. 2019;41(1-2):139-148
pubmed: 31430754
Genome Med. 2016 Jan 06;8(1):3
pubmed: 26739615
Am J Hum Genet. 2016 Mar 3;98(3):541-552
pubmed: 26942287
Nat Med. 2019 Jun;25(6):911-919
pubmed: 31160820
Nat Protoc. 2021 Feb;16(2):1276-1296
pubmed: 33462443
Eur J Hum Genet. 2022 Jan;30(1):95-100
pubmed: 34645992
Genet Med. 2020 Mar;22(3):490-499
pubmed: 31607746
Cell. 2019 Jan 24;176(3):535-548.e24
pubmed: 30661751
J Med Internet Res. 2020 Jan 30;22(1):e16204
pubmed: 32012066
Genome Med. 2021 Feb 22;13(1):31
pubmed: 33618777
J Hum Genet. 2016 Apr;61(4):357-9
pubmed: 26763879
Hum Genet. 2017 Jun;136(6):679-691
pubmed: 28303347

Auteurs

Ashanta Merriweather (A)

Meharry Medical College, Nashville, Tennessee, USA.

David R Murdock (DR)

Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, Texas, USA.

Jill A Rosenfeld (JA)

Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, Texas, USA.

Hongzheng Dai (H)

Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Baylor Genetics, Houston, Texas, USA.

Shamika Ketkar (S)

Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, Texas, USA.

Lisa Emrick (L)

Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Texas Children's Hospital, Houston, Texas, USA.
Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
Division of Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.

Sarah Nicholas (S)

Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
Pediatric Immunology, Allergy, and Retrovirology, Texas Children's Hospital, Houston, Texas, USA.

Richard A Lewis (RA)

Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Texas Children's Hospital, Houston, Texas, USA.
Cullen Eye Institute, Department of Ophthalmology, Baylor College of Medicine, Houston, Texas, USA.

Carlos A Bacino (CA)

Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Texas Children's Hospital, Houston, Texas, USA.

Daryl A Scott (DA)

Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Texas Children's Hospital, Houston, Texas, USA.
Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, Texas, USA.

Brendan Lee (B)

Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Texas Children's Hospital, Houston, Texas, USA.

Vernon Reid Sutton (VR)

Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Texas Children's Hospital, Houston, Texas, USA.

Lorraine Potocki (L)

Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Texas Children's Hospital, Houston, Texas, USA.

Lindsay C Burrage (LC)

Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Texas Children's Hospital, Houston, Texas, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH